Medicare and Medicaid Programs: Accreditation Commission for Health Care, Inc (ACHC) for Approval of its End Stage Renal Disease (ESRD) Facility Accreditation Program, 55172-55174 [2018-23925]
Download as PDF
55172
Federal Register / Vol. 83, No. 213 / Friday, November 2, 2018 / Notices
the causes, diagnosis, treatment, control,
and prevention of physical and mental
diseases, and other impairments; (2)
assist States and their political
subdivisions in preventing and
suppressing communicable and noncommunicable diseases and other
preventable conditions and in
promoting health and well-being; and
(3) conduct and assist in research and
control activities related to injury. The
Board of Scientific Counselors makes
recommendations regarding policies,
strategies, objectives, and priorities; and
reviews progress toward injury
prevention goals and provides evidence
in injury prevention-related research
and programs. The Board also provides
advice on the appropriate balance of
intramural and extramural research, the
structure, progress and performance of
intramural programs. The Board is
designed to provide guidance on
extramural scientific program matters,
including the: (1) Review of extramural
research concepts for funding
opportunity announcements; (2)
conduct of Secondary Peer Review of
extramural research grants, cooperative
agreements, and contracts applications
received in response to the funding
opportunity announcements as it relates
to the Center’s programmatic balance
and mission; (3) submission of
secondary review recommendations to
the Center Director of applications to be
considered for funding support; (4)
review of research portfolios, and (5)
review of program proposals.
Matters to be Considered: The Board
of Scientific Counselors will discuss
science matters to include research
strategies needed to guide the Center’s
focus on reducing opioid overdose and
to review the recommendations from the
opioid prescribing for acute and chronic
pain workgroup. Agenda items are
subject to change as priorities dictate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2018–23976 Filed 11–1–18; 8:45 am]
BILLING CODE 4163–19–P
VerDate Sep<11>2014
17:57 Nov 01, 2018
Jkt 247001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Council for the Elimination of
Tuberculosis Meeting (ACET)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
of the Advisory Council for the
Elimination of Tuberculosis Meeting
(ACET). This meeting is open to the
public, limited only by the space
available. The meeting room
accommodates approximately 80 people
and has 100 ports for audio phone lines.
Time will be available for public
comment. The public is welcome to
submit written comments in advance of
the meeting. Comments should be
submitted in writing by email to the
contact person listed below. The
deadline for receipt is Monday,
December 10, 2018. Persons who desire
to make an oral statement, may request
it at the time of the public comment
period on December 12, 2018 at 11:40
a.m., EST.
DATES: The meeting will be held on
December 11, 2018, 8:30 a.m. to 4:30
p.m., EST and December 12, 2018, 8:30
a.m. to 12:00 p.m., EST.
ADDRESSES: 8 Corporate Blvd., Building
8, Conference Rooms 1–A/B/C, Atlanta,
Georgia, 30329 and Web conference: 1–
877–927–1433 and participant
passcode: 12016435 and https://
adobeconnect.cdc.gov/r5p8l2tytpq/.
FOR FURTHER INFORMATION CONTACT:
Margie Scott-Cseh, Committee
Management Specialist, CDC, 1600
Clifton Road, NE, Mailstop: E–07,
Atlanta, Georgia, 30333, telephone (404)
639–8317; zkr7@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: This Council advises and
makes recommendations to the
Secretary of Health and Human
Services, the Assistant Secretary for
Health, and the Director, CDC, regarding
the elimination of tuberculosis.
Specifically, the Council makes
recommendations regarding policies,
strategies, objectives, and priorities;
addresses the development and
application of new technologies; and
reviews the extent to which progress has
been made toward eliminating
tuberculosis.
Matters to be Considered: The agenda
will include discussions on (1) Division
SUMMARY:
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
of Tuberculosis Elimination (DTBE)
funded Demonstration Project on Latent
Tuberculosis Infection (LTBI) Testing
and Treatment; (2) DTBE
Communications Messaging and
Campaigns; (3) Update on LTBI
Treatment Guidelines; (4) Update on
Drug Resistant Tuberculosis Guidelines;
and (5) Update from ACET workgroups.
Agenda items are subject to change as
priorities dictate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2018–23974 Filed 11–1–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3371–PN]
Medicare and Medicaid Programs:
Accreditation Commission for Health
Care, Inc (ACHC) for Approval of its
End Stage Renal Disease (ESRD)
Facility Accreditation Program
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice with request for
comment.
AGENCY:
This proposed notice
acknowledges the receipt of an
application from the Accreditation
Commission for Health Care, Inc., for
recognition as a national accrediting
organization for End Stage Renal
Disease Facilities that wish to
participate in the Medicare or Medicaid
programs.
DATES: To be assured consideration,
comments must be received at one of
the addresses provided below, no later
than 5 p.m. on December 3, 2018.
ADDRESSES: In commenting, refer to file
code CMS–3371–PN. Because of staff
and resource limitations, we cannot
accept comments by facsimile (FAX)
transmission.
Comments, including mass comment
submissions, must be submitted in one
of the following three ways (please
choose only one of the ways listed):
SUMMARY:
E:\FR\FM\02NON1.SGM
02NON1
Federal Register / Vol. 83, No. 213 / Friday, November 2, 2018 / Notices
1. Electronically. You may submit
electronic comments on this regulation
to https://www.regulations.gov. Follow
the ‘‘Submit a comment’’ instructions.
2. By regular mail. You may mail
written comments to the following
address ONLY: Centers for Medicare &
Medicaid Services, Department of
Health and Human Services, Attention:
CMS–3371–PN, P.O. Box 8010,
Baltimore, MD 21244–8010.
Please allow sufficient time for mailed
comments to be received before the
close of the comment period.
3. By express or overnight mail. You
may send written comments to the
following address ONLY: Centers for
Medicare & Medicaid Services,
Department of Health and Human
Services, Attention: CMS–3371–PN,
Mail Stop C4–26–05, 7500 Security
Boulevard, Baltimore, MD 21244–1850.
For information on viewing public
comments, see the beginning of the
SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT:
Monda Shaver, (410) 786–3410, Joann
Fitzell, (410) 786–4280, or Renee Henry,
(410) 786–7828.
SUPPLEMENTARY INFORMATION:
Inspection of Public Comments: All
comments received before the close of
the comment period are available for
viewing by the public, including any
personally identifiable or confidential
business information that is included in
a comment. We post all comments
received before the close of the
comment period on the following
website as soon as possible after they
have been received: https://
www.regulations.gov. Follow the search
instructions on that website to view
public comments.
I. Background
Under the Medicare program, eligible
beneficiaries may receive covered
services from an end-stage renal disease
(ESRD) facility provided the facility
meets the requirements established by
the Secretary of the Department of
Health and Human Services (the
Secretary). Section 1881(b) of the Social
Security Act (the Act) establishes
distinct requirements for facilities
seeking designation as an ESRD facility
under Medicare. Regulations concerning
provider agreements and supplier
approval are at 42 CFR part 489 and
those pertaining to activities relating to
the survey, certification, and
enforcement procedures of suppliers
which include ESRD facilities are at 42
CFR part 488. The regulations at 42 CFR
part 494 subparts A through D
implement section 1881(b) of the Act,
which specify the conditions that an
VerDate Sep<11>2014
17:57 Nov 01, 2018
Jkt 247001
ESRD facility must meet in order to
participate in the Medicare program and
the conditions for Medicare payment for
ESRD facilities.
Generally, to enter into a Medicare
agreement, an ESRD facility must first
be certified by a State survey agency
(SA) as complying with the conditions
or requirements set forth in part 494
subparts A through D of our Medicare
regulations. Thereafter, the ESRD
facility is subject to regular surveys by
a SA to determine whether it continues
to meet these requirements.
Section 1865(a)(1) of the Act provides
that, if a provider entity demonstrates
through accreditation by a Centers for
Medicare & Medicaid Services (CMS)
approved national accrediting
organization (AO) that all applicable
Medicare conditions are met or
exceeded, we may deem those provider
entities as having met the requirements.
Section 1865(a)(1) of the Act had
historically excluded dialysis facilities
from participating in Medicare via a
CMS-approved accreditation program;
however, section 50404 of the
Bipartisan Budget Act of 2018 amended
section 1865(a) of the Act to include
renal dialysis facilities as provider
entities allowed to participate in
Medicare through a CMS-approved
accreditation program. Accreditation by
an AO is voluntary and is not required
for Medicare participation.
If an AO is recognized by the
Secretary as having standards for
accreditation that meet or exceed
Medicare requirements, any provider
entity accredited by the national
accrediting body’s approved program
may be deemed to meet the Medicare
conditions. An AO applying for
approval of its accreditation program
under part 488, subpart A, must provide
CMS with reasonable assurance that the
AO requires the accredited provider
entities to meet requirements that are at
least as stringent as the Medicare
conditions. Our regulations concerning
the approval of AOs are set forth at
§ 488.5.
II. Provisions of the Proposed Notice
A. Approval of Deeming Organizations
Section 1865(a)(2) of the Act and our
regulations at § 488.5 require that our
findings concerning review and
approval of an AO’s requirements
consider, among other factors, the
applying AO’s requirements for
accreditation; survey procedures;
resources for conducting required
surveys; capacity to furnish information
for use in enforcement activities;
monitoring procedures for provider
entities found not in compliance with
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
55173
the conditions or requirements; and
ability to provide CMS with the
necessary data for validation.
Section 1865(a)(3)(A) of the Act
further requires that we publish, within
60 days of receipt of an organization’s
complete application, a notice
identifying the national accrediting
body making the request, describing the
nature of the request, and providing at
least a 30-day public comment period.
We have 210 days from the receipt of a
complete application to publish notice
of approval or denial of the application.
The purpose of this proposed notice
is to inform the public of Accreditation
Commission for Health Care, Inc.’s
(ACHC’s) request for CMS-approval of
its ESRD facility accreditation program.
This notice also solicits public comment
on whether ACHC’s requirements meet
or exceed the Medicare conditions for
coverage (CfCs) for ESRD facilities.
B. Evaluation of Deeming Authority
Request
ACHC submitted all the necessary
materials to enable us to make a
determination concerning its request for
CMS-approval of its ESRD facility
accreditation program. This application
was determined to be complete on
September 13, 2018. Under section
1865(a)(2) of the Act and regulations at
§ 488.5, our review and evaluation of
ACHC will be conducted in accordance
with, but not necessarily limited to, the
following factors:
• The equivalency of ACHC’s
standards for ESRD facilities as
compared with Medicare’s CfCs for
ESRD facilities.
• ACHC’s survey process to
determine the following:
++ The composition of the survey
team, surveyor qualifications, and the
ability of the organization to provide
continuing surveyor training.
++ The comparability of ACHC’s
processes to those of State agencies,
including survey frequency, and the
ability to investigate and respond
appropriately to complaints against
accredited facilities.
++ ACHC’s processes and procedures
for monitoring an ESRD facility found
out of compliance with ACHC’s program
requirements. These monitoring
procedures are used only when ACHC
identifies noncompliance. If
noncompliance is identified through
validation reviews or complaint
surveys, the State survey agency
monitors corrections as specified at
§ 488.9(c)(1).
++ ACHC’s capacity to report
deficiencies to the surveyed facilities
and respond to the facility’s plan of
correction in a timely manner.
E:\FR\FM\02NON1.SGM
02NON1
55174
Federal Register / Vol. 83, No. 213 / Friday, November 2, 2018 / Notices
III. Collection of Information
Requirements
This document does not impose
information collection requirements,
that is, reporting, recordkeeping or
third-party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35).
SUPPLEMENTARY INFORMATION:
I. Background
The Centers for Medicare & Medicaid
Services (CMS) is responsible for
administering the Medicare and
Medicaid programs and coordination
and oversight of private health
insurance. Administration and oversight
of these programs involves the
following: (1) Furnishing information to
Medicare and Medicaid beneficiaries,
health care providers, and the public;
and (2) maintaining effective
communications with CMS regional
VerDate Sep<11>2014
17:57 Nov 01, 2018
Jkt 247001
IV. Response to Public Comments
Because of the large number of public
comments we normally receive on
Federal Register documents, we are not
able to acknowledge or respond to them
individually. We will consider all
comments we receive by the date and
time specified in the DATES section of
this preamble, and, when we proceed
with a subsequent document, we will
respond to the comments in the
preamble to that document.
Upon completion of our evaluation,
including evaluation of comments
received as a result of this notice, we
will publish a final notice in the Federal
Register announcing the result of our
evaluation.
Dated: October 19, 2018.
Seema Verma,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. 2018–23925 Filed 11–1–18; 8:45 am]
BILLING CODE 4120–01–P
offices, state governments, state
Medicaid agencies, state survey
agencies, various providers of health
care, all Medicare contractors that
process claims and pay bills, National
Association of Insurance Commissioners
(NAIC), health insurers, and other
stakeholders. To implement the various
statutes on which the programs are
based, we issue regulations under the
authority granted to the Secretary of the
Department of Health and Human
Services under sections 1102, 1871,
1902, and related provisions of the
Social Security Act (the Act) and Public
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–9111–N]
Medicare and Medicaid Programs;
Quarterly Listing of Program Issua
nces—July Through September 2018
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
This quarterly notice lists
CMS manual instructions, substantive
and interpretive regulations, and other
Federal Register notices that were
published from July through September
2018, relating to the Medicare and
Medicaid programs and other programs
administered by CMS.
FOR FURTHER INFORMATION CONTACT: It is
possible that an interested party may
need specific information and not be
able to determine from the listed
information whether the issuance or
regulation would fulfill that need.
Consequently, we are providing contact
persons to answer general questions
concerning each of the addenda
published in this notice.
SUMMARY:
Health Service Act. We also issue
various manuals, memoranda, and
statements necessary to administer and
oversee the programs efficiently.
Section 1871(c) of the Act requires
that we publish a list of all Medicare
manual instructions, interpretive rules,
statements of policy, and guidelines of
general applicability not issued as
regulations at least every 3 months in
the Federal Register.
E:\FR\FM\02NON1.SGM
02NON1
EN02No18.000
++ ACHC’s capacity to provide CMS
with electronic data and reports
necessary for effective validation and
assessment of the organization’s survey
process.
++ The adequacy of ACHC’s staff and
other resources, and its financial
viability.
++ ACHC’s capacity to adequately
fund required surveys.
++ ACHC’s policies with respect to
whether surveys are announced or
unannounced, to assure that surveys are
unannounced.
++ ACHC’s agreement to provide
CMS with a copy of the most current
accreditation survey together with any
other information related to the survey
as CMS may require (including
corrective action plans).
Agencies
[Federal Register Volume 83, Number 213 (Friday, November 2, 2018)]
[Notices]
[Pages 55172-55174]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-23925]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3371-PN]
Medicare and Medicaid Programs: Accreditation Commission for
Health Care, Inc (ACHC) for Approval of its End Stage Renal Disease
(ESRD) Facility Accreditation Program
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice with request for comment.
-----------------------------------------------------------------------
SUMMARY: This proposed notice acknowledges the receipt of an
application from the Accreditation Commission for Health Care, Inc.,
for recognition as a national accrediting organization for End Stage
Renal Disease Facilities that wish to participate in the Medicare or
Medicaid programs.
DATES: To be assured consideration, comments must be received at one of
the addresses provided below, no later than 5 p.m. on December 3, 2018.
ADDRESSES: In commenting, refer to file code CMS-3371-PN. Because of
staff and resource limitations, we cannot accept comments by facsimile
(FAX) transmission.
Comments, including mass comment submissions, must be submitted in
one of the following three ways (please choose only one of the ways
listed):
[[Page 55173]]
1. Electronically. You may submit electronic comments on this
regulation to https://www.regulations.gov. Follow the ``Submit a
comment'' instructions.
2. By regular mail. You may mail written comments to the following
address ONLY: Centers for Medicare & Medicaid Services, Department of
Health and Human Services, Attention: CMS-3371-PN, P.O. Box 8010,
Baltimore, MD 21244-8010.
Please allow sufficient time for mailed comments to be received
before the close of the comment period.
3. By express or overnight mail. You may send written comments to
the following address ONLY: Centers for Medicare & Medicaid Services,
Department of Health and Human Services, Attention: CMS-3371-PN, Mail
Stop C4-26-05, 7500 Security Boulevard, Baltimore, MD 21244-1850.
For information on viewing public comments, see the beginning of
the SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT: Monda Shaver, (410) 786-3410, Joann
Fitzell, (410) 786-4280, or Renee Henry, (410) 786-7828.
SUPPLEMENTARY INFORMATION:
Inspection of Public Comments: All comments received before the
close of the comment period are available for viewing by the public,
including any personally identifiable or confidential business
information that is included in a comment. We post all comments
received before the close of the comment period on the following
website as soon as possible after they have been received: https://www.regulations.gov. Follow the search instructions on that website to
view public comments.
I. Background
Under the Medicare program, eligible beneficiaries may receive
covered services from an end-stage renal disease (ESRD) facility
provided the facility meets the requirements established by the
Secretary of the Department of Health and Human Services (the
Secretary). Section 1881(b) of the Social Security Act (the Act)
establishes distinct requirements for facilities seeking designation as
an ESRD facility under Medicare. Regulations concerning provider
agreements and supplier approval are at 42 CFR part 489 and those
pertaining to activities relating to the survey, certification, and
enforcement procedures of suppliers which include ESRD facilities are
at 42 CFR part 488. The regulations at 42 CFR part 494 subparts A
through D implement section 1881(b) of the Act, which specify the
conditions that an ESRD facility must meet in order to participate in
the Medicare program and the conditions for Medicare payment for ESRD
facilities.
Generally, to enter into a Medicare agreement, an ESRD facility
must first be certified by a State survey agency (SA) as complying with
the conditions or requirements set forth in part 494 subparts A through
D of our Medicare regulations. Thereafter, the ESRD facility is subject
to regular surveys by a SA to determine whether it continues to meet
these requirements.
Section 1865(a)(1) of the Act provides that, if a provider entity
demonstrates through accreditation by a Centers for Medicare & Medicaid
Services (CMS) approved national accrediting organization (AO) that all
applicable Medicare conditions are met or exceeded, we may deem those
provider entities as having met the requirements. Section 1865(a)(1) of
the Act had historically excluded dialysis facilities from
participating in Medicare via a CMS-approved accreditation program;
however, section 50404 of the Bipartisan Budget Act of 2018 amended
section 1865(a) of the Act to include renal dialysis facilities as
provider entities allowed to participate in Medicare through a CMS-
approved accreditation program. Accreditation by an AO is voluntary and
is not required for Medicare participation.
If an AO is recognized by the Secretary as having standards for
accreditation that meet or exceed Medicare requirements, any provider
entity accredited by the national accrediting body's approved program
may be deemed to meet the Medicare conditions. An AO applying for
approval of its accreditation program under part 488, subpart A, must
provide CMS with reasonable assurance that the AO requires the
accredited provider entities to meet requirements that are at least as
stringent as the Medicare conditions. Our regulations concerning the
approval of AOs are set forth at Sec. 488.5.
II. Provisions of the Proposed Notice
A. Approval of Deeming Organizations
Section 1865(a)(2) of the Act and our regulations at Sec. 488.5
require that our findings concerning review and approval of an AO's
requirements consider, among other factors, the applying AO's
requirements for accreditation; survey procedures; resources for
conducting required surveys; capacity to furnish information for use in
enforcement activities; monitoring procedures for provider entities
found not in compliance with the conditions or requirements; and
ability to provide CMS with the necessary data for validation.
Section 1865(a)(3)(A) of the Act further requires that we publish,
within 60 days of receipt of an organization's complete application, a
notice identifying the national accrediting body making the request,
describing the nature of the request, and providing at least a 30-day
public comment period. We have 210 days from the receipt of a complete
application to publish notice of approval or denial of the application.
The purpose of this proposed notice is to inform the public of
Accreditation Commission for Health Care, Inc.'s (ACHC's) request for
CMS-approval of its ESRD facility accreditation program. This notice
also solicits public comment on whether ACHC's requirements meet or
exceed the Medicare conditions for coverage (CfCs) for ESRD facilities.
B. Evaluation of Deeming Authority Request
ACHC submitted all the necessary materials to enable us to make a
determination concerning its request for CMS-approval of its ESRD
facility accreditation program. This application was determined to be
complete on September 13, 2018. Under section 1865(a)(2) of the Act and
regulations at Sec. 488.5, our review and evaluation of ACHC will be
conducted in accordance with, but not necessarily limited to, the
following factors:
The equivalency of ACHC's standards for ESRD facilities as
compared with Medicare's CfCs for ESRD facilities.
ACHC's survey process to determine the following:
++ The composition of the survey team, surveyor qualifications, and
the ability of the organization to provide continuing surveyor
training.
++ The comparability of ACHC's processes to those of State
agencies, including survey frequency, and the ability to investigate
and respond appropriately to complaints against accredited facilities.
++ ACHC's processes and procedures for monitoring an ESRD facility
found out of compliance with ACHC's program requirements. These
monitoring procedures are used only when ACHC identifies noncompliance.
If noncompliance is identified through validation reviews or complaint
surveys, the State survey agency monitors corrections as specified at
Sec. 488.9(c)(1).
++ ACHC's capacity to report deficiencies to the surveyed
facilities and respond to the facility's plan of correction in a timely
manner.
[[Page 55174]]
++ ACHC's capacity to provide CMS with electronic data and reports
necessary for effective validation and assessment of the organization's
survey process.
++ The adequacy of ACHC's staff and other resources, and its
financial viability.
++ ACHC's capacity to adequately fund required surveys.
++ ACHC's policies with respect to whether surveys are announced or
unannounced, to assure that surveys are unannounced.
++ ACHC's agreement to provide CMS with a copy of the most current
accreditation survey together with any other information related to the
survey as CMS may require (including corrective action plans).
III. Collection of Information Requirements
This document does not impose information collection requirements,
that is, reporting, recordkeeping or third-party disclosure
requirements. Consequently, there is no need for review by the Office
of Management and Budget under the authority of the Paperwork Reduction
Act of 1995 (44 U.S.C. Chapter 35).
IV. Response to Public Comments
Because of the large number of public comments we normally receive
on Federal Register documents, we are not able to acknowledge or
respond to them individually. We will consider all comments we receive
by the date and time specified in the DATES section of this preamble,
and, when we proceed with a subsequent document, we will respond to the
comments in the preamble to that document.
Upon completion of our evaluation, including evaluation of comments
received as a result of this notice, we will publish a final notice in
the Federal Register announcing the result of our evaluation.
Dated: October 19, 2018.
Seema Verma,
Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 2018-23925 Filed 11-1-18; 8:45 am]
BILLING CODE 4120-01-P